Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $115,229 - $230,459
-50,100 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$2.9 - $9.56 $123,250 - $406,300
-42,500 Reduced 45.9%
50,100 $145,000
Q2 2019

Aug 14, 2019

BUY
$6.7 - $9.13 $285,420 - $388,938
42,600 Added 85.2%
92,600 $816,000
Q1 2019

May 14, 2019

SELL
$5.7 - $8.73 $68,308 - $104,620
-11,984 Reduced 19.33%
50,000 $370,000
Q4 2018

Feb 13, 2019

SELL
$5.04 - $10.28 $396,728 - $809,200
-78,716 Reduced 55.95%
61,984 $377,000
Q3 2018

Nov 14, 2018

BUY
$7.12 - $12.44 $574,584 - $1 Million
80,700 Added 134.5%
140,700 $1.32 Million
Q2 2018

Aug 14, 2018

BUY
$6.21 - $8.21 $372,600 - $492,600
60,000 New
60,000 $415,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Amtrust Financial Services, Inc. Portfolio

Follow Amtrust Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amtrust Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Amtrust Financial Services, Inc. with notifications on news.